• Subscription revenue up 6% to $6.325M
• EBITDAR of $1.335M representing 18% of revenue
• Embracing AI to improve productivity and efficiency

Global Health Ltd (ASX:GLH) has announced its FY 2025 results, reporting further progress back to profitability. Total income was flat compared to the previous corresponding period, despite the loss of $750K of revenue from SA Health as they completed their transition to a statewide PAS and EMR. The company's CHIRON PAS used in country hospitals since 1995 was retired. Subscription revenue was up 6% to $6.325M, with 30 new-logo clients signed over the year, ranging from large, multiple location service providers to smaller providers. The company reported an EBITDAR of $1.335M, representing 18% of revenue. Operating expenses increased slightly in line with market demands, as the company prioritised customer satisfaction. The company has embraced AI to improve productivity and efficiency, with over 70% of support tickets resolved with low-touch AI avatars. The company has also implemented AI enhancements across its product suite, including AI Scribes in MasterCare, triage avatars in HotHealth, and personal health coaching avatars in Lifecard. At an EBITDA level, with R&D fully expensed, the trend was positive, with EBITDA improving by over 37% to ($760K) from the previous corresponding period. The company is focused on completing the transition of its on-premise applications to a multi-tenancy SaaS platform, incremental sales and deployments of its value-add portfolio, and enabling the implementation of digital solutions to replace paper and enable the application of AI for improved patient outcomes and service provider productivity.

The company expects to continue the trend of reducing R&D as a percentage of expenses, with R&D expected to revert to an industry standard ratio of 15% of expenses. The company's Lifecard Personal Health Record is expected to be a key focus, with the technology update expected to be completed in the first quarter of FY2026 and active promotion through FY2026.

The company is focused on completing the transition of its on-premise applications to a multi-tenancy SaaS platform, incremental sales and deployments of its value-add portfolio, and enabling the implementation of digital solutions to replace paper and enable the application of AI for improved patient outcomes and service provider productivity. The company is also engaging with partner sales channels locally and overseas to develop indirect sales channels.